Literature DB >> 2424080

HLA-DR expression and disease activity in ulcerative colitis.

L O Poulsen, P Elling, F B Sørensen, K Høedt-Rasmussen.   

Abstract

In 12 patients with active ulcerative colitis (UC) the rectal epithelial cells were analyzed for HLA-DR antigens by an immunohistochemical technique. The clinical, rectoscopic, and histologic stages were also determined. The investigations were carried out at the beginning of the study and 2 weeks and 3 months later. The rectal epithelial cells were HLA-DR-positive in all patients at the first two examinations. After 3 months five patients had changed to an HLA-DR-negative stage, whereas the other seven patients remained HLA-DR-positive. Closer analyses showed that expression/nonexpression of HLA-DR antigens on rectal epithelial cells of patients with UC could not be predicted from the clinical, rectoscopic, or histologic findings. HLA-DR expression is normally restricted to immunocompetent cells. The presence of HLA-DR antigens on epithelial cells may be a consequence of immunological reactions. Whether HLA-DR-positive cells have a specific function is unknown.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424080     DOI: 10.3109/00365528609003088

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Spondylodiscitis and pseudarthrosis in a patient with enteropathic spondyloarthropathy.

Authors:  A Calin; D Robertson
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 2.  Distinctive diffuse duodenitis associated with ulcerative colitis.

Authors:  H Mitomi; E Atari; H Uesugi; Y Nishiyama; M Igarashi; N Arai; A Ihara; I Okayasu
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

3.  Expression of HLA-DR antigens on colonic epithelium in ulcerative colitis.

Authors:  M Iizuka; M Chiba; H Ohta; K Kodama; K Igarashi; H Arakawa; O Masamune
Journal:  Gastroenterol Jpn       Date:  1987-10

4.  Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis.

Authors:  T O Rognum; P Brandtzaeg; K Elgjo; O Fausa
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.